Compare VCEL & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VCEL | ICHR |
|---|---|---|
| Founded | 1989 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 1996 | 2016 |
| Metric | VCEL | ICHR |
|---|---|---|
| Price | $35.06 | $63.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $57.75 | $49.50 |
| AVG Volume (30 Days) | ★ 702.1K | 615.0K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | $276,259,000.00 | ★ $947,652,000.00 |
| Revenue This Year | $19.10 | $19.98 |
| Revenue Next Year | $17.95 | $15.92 |
| P/E Ratio | $110.64 | ★ N/A |
| Revenue Growth | ★ 16.45 | 11.61 |
| 52 Week Low | $28.95 | $13.15 |
| 52 Week High | $45.97 | $65.58 |
| Indicator | VCEL | ICHR |
|---|---|---|
| Relative Strength Index (RSI) | 58.72 | 73.34 |
| Support Level | $34.26 | $15.58 |
| Resistance Level | $38.48 | N/A |
| Average True Range (ATR) | 1.37 | 3.52 |
| MACD | 0.46 | 1.60 |
| Stochastic Oscillator | 94.67 | 93.58 |
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.